Investors Urged to Take Action in Reckitt Benckiser Class Action Lawsuit
New York and New Orleans, June 24, 2025—Kahn Swick & Foti, LLC (KSF), alongside former Louisiana Attorney General Charles C. Foti, Jr., is notifying investors of a key deadline in a securities class action lawsuit against Reckitt Benckiser Group PLC. Investors who purchased Reckitt’s American Depositary Shares (ADSs) from January 13, 2021, to July 28, 2024, have until August 4, 2025, to apply as lead plaintiffs in the case, currently pending in the U.S. District Court for the Southern District of New York.
The lawsuit alleges that Reckitt and certain executives failed to disclose critical information regarding the risks associated with the consumption of their cow’s milk-based formula, Enfamil, which may lead to necrotizing enterocolitis (NEC) in preterm infants. These omissions allegedly resulted in misleading statements about the company’s performance and prospects.
Interested investors can contact KSF Managing Partner Lewis Kahn for a consultation at no cost. KSF, a leading boutique securities litigation firm, has a proven track record in advocating for investors against corporate misconduct. For further details, visit www.ksfcounsel.com.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
